Literature DB >> 19706774

Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination.

Natalie M Moss1, Maria V Barbolina, Yueying Liu, Limin Sun, Hidayatullah G Munshi, M Sharon Stack.   

Abstract

An early event in the metastasis of epithelial ovarian carcinoma is shedding of cells from the primary tumor into the peritoneal cavity followed by diffuse i.p. seeding of secondary lesions. Anchorage-independent metastatic cells are present as both single cells and multicellular aggregates (MCA), the latter of which adhere to and disaggregate on human mesothelial cell monolayers, subsequently forming invasive foci. Although this unique metastatic mechanism presents a distinct set of therapeutic challenges, factors that regulate MCA formation and dissemination have not been extensively evaluated. Proteolytic activity is important at multiple stages in i.p. metastasis, catalyzing migration through the mesothelial monolayer and invasion of the collagen-rich submesothelial matrix to anchor secondary lesions, and acquisition of membrane type 1 matrix metalloproteinase (MT1-MMP; MMP-14) expression promotes a collagen-invasive phenotype in ovarian carcinoma. MT1-MMP is regulated posttranslationally through multiple mechanisms including phosphorylation of its cytoplasmic tail, and the current data using ovarian cancer cells expressing wild-type, phosphomimetic (T567E-MT1-MMP), and phosphodefective (T567A-MT1-MMP) MT1-MMP show that MT1-MMP promotes MCA formation. Confluent T567E-MT1-MMP-expressing cells exhibit rapid detachment kinetics, spontaneous release as cell-cell adherent sheets concomitant with MT1-MMP-catalyzed alpha(3) integrin ectodomain shedding, and robust MCA formation. Expansive growth within three-dimensional collagen gels is also MT1-MMP dependent, with T567E-MT1-MMP-expressing cells exhibiting multiple collagen invasive foci. Analysis of human ovarian tumors shows elevated MT1-MMP in metastases relative to paired primary tumors. These data suggest that MT1-MMP activity may be key to ovarian carcinoma metastatic success by promoting both formation and dissemination of MCAs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706774      PMCID: PMC2737080          DOI: 10.1158/0008-5472.CAN-08-4151

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling.

Authors:  Egle Avizienyte; Anne W Wyke; Robert J Jones; Gordon W McLean; M Andrew Westhoff; Valerie G Brunton; Margaret C Frame
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

2.  Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix.

Authors:  Kevin B Hotary; Edward D Allen; Peter C Brooks; Nabanita S Datta; Michael W Long; Stephen J Weiss
Journal:  Cell       Date:  2003-07-11       Impact factor: 41.582

3.  Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L).

Authors:  A Frankel; K Rosen; J Filmus; R S Kerbel
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

4.  Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids.

Authors:  R C Casey; K M Burleson; K M Skubitz; S E Pambuccian; T R Oegema; L E Ruff; A P Skubitz
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 5.  Tumor microenvironment: what can effusions teach us?

Authors:  Jareer Kassis; Julius Klominek; Elise C Kohn
Journal:  Diagn Cytopathol       Date:  2005-11       Impact factor: 1.582

6.  Composition of the extracellular matrix of the peritoneum.

Authors:  C A Witz; I A Montoya-Rodriguez; S Cho; V E Centonze; L F Bonewald; R S Schenken
Journal:  J Soc Gynecol Investig       Date:  2001 Sep-Oct

7.  Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types.

Authors:  Jens M Kelm; Nicholas E Timmins; Catherine J Brown; Martin Fussenegger; Lars K Nielsen
Journal:  Biotechnol Bioeng       Date:  2003-07-20       Impact factor: 4.530

8.  Identification and characterization of ovarian cancer-initiating cells from primary human tumors.

Authors:  Shu Zhang; Curt Balch; Michael W Chan; Hung-Cheng Lai; Daniela Matei; Jeanne M Schilder; Pearlly S Yan; Tim H-M Huang; Kenneth P Nephew
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

9.  Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines.

Authors:  Neal Al Cody; Magdalena Zietarska; Ali Filali-Mouhim; Diane M Provencher; Anne-Marie Mes-Masson; Patricia N Tonin
Journal:  BMC Med Genomics       Date:  2008-08-07       Impact factor: 3.063

10.  MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells.

Authors:  K L Sodek; M J Ringuette; T J Brown
Journal:  Br J Cancer       Date:  2007-07-03       Impact factor: 7.640

View more
  43 in total

1.  Phosphorylation of membrane type 1-matrix metalloproteinase (MT1-MMP) and its vesicle-associated membrane protein 7 (VAMP7)-dependent trafficking facilitate cell invasion and migration.

Authors:  Karla C Williams; Marc G Coppolino
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

2.  Membrane type 1 matrix metalloproteinase (MT1-MMP) ubiquitination at Lys581 increases cellular invasion through type I collagen.

Authors:  Patricia A Eisenach; Pedro Corrêa de Sampaio; Gillian Murphy; Christian Roghi
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

Review 3.  Epithelial ovarian cancer experimental models.

Authors:  E Lengyel; J E Burdette; H A Kenny; D Matei; J Pilrose; P Haluska; K P Nephew; D B Hales; M S Stack
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

4.  In vivo optical imaging of membrane-type matrix metalloproteinase (MT-MMP) activity.

Authors:  Lei Zhu; Fan Zhang; Ying Ma; Gang Liu; Kwangmeyung Kim; Xuexun Fang; Seulki Lee; Xiaoyuan Chen
Journal:  Mol Pharm       Date:  2011-11-01       Impact factor: 4.939

Review 5.  Intraoperative imaging in ovarian cancer: fact or fiction?

Authors:  Lucia M A Crane; Marleen van Oosten; Rick G Pleijhuis; Arash Motekallemi; Sean C Dowdy; William A Cliby; Ate G J van der Zee; Gooitzen M van Dam
Journal:  Mol Imaging       Date:  2011-04-26       Impact factor: 4.488

6.  Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells.

Authors:  Sharmila A Bapat; Victor Jin; Nicholas Berry; Curt Balch; Neeti Sharma; Nawneet Kurrey; Shu Zhang; Fang Fang; Xun Lan; Meng Li; Brian Kennedy; Robert M Bigsby; Tim H M Huang; Kenneth P Nephew
Journal:  Epigenetics       Date:  2010-11-01       Impact factor: 4.528

7.  The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment.

Authors:  Raju R Rayavarapu; Brendan Heiden; Nicholas Pagani; Melissa M Shaw; Sydney Shuff; Siyuan Zhang; Zachary T Schafer
Journal:  J Biol Chem       Date:  2015-02-13       Impact factor: 5.157

8.  Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer.

Authors:  Rajani Kaimal; Raid Aljumaily; Sarah L Tressel; Rutika V Pradhan; Lidija Covic; Athan Kuliopulos; Corrine Zarwan; Young B Kim; Sheida Sharifi; Anika Agarwal
Journal:  Cancer Res       Date:  2013-02-19       Impact factor: 12.701

9.  Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 protein.

Authors:  Maria V Barbolina; Yiuying Liu; Hilal Gurler; Mijung Kim; Andre A Kajdacsy-Balla; Lisa Rooper; Jaclyn Shepard; Michael Weiss; Lonnie D Shea; Peter Penzes; Matthew J Ravosa; M Sharon Stack
Journal:  J Biol Chem       Date:  2012-11-14       Impact factor: 5.157

Review 10.  EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.

Authors:  Laurie G Hudson; Natalie M Moss; M Sharon Stack
Journal:  Future Oncol       Date:  2009-04       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.